The University of Chicago Header Logo

Connection

Elaine M. Worcester to Osteopontin

This is a "connection" page, showing publications Elaine M. Worcester has written about Osteopontin.
Connection Strength

0.317
  1. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60.
    View in: PubMed
    Score: 0.092
  2. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54.
    View in: PubMed
    Score: 0.066
  3. Osteopontin production by cultured kidney cells. Ann N Y Acad Sci. 1995 Apr 21; 760:266-78.
    View in: PubMed
    Score: 0.032
  4. Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci. 1995 Apr 21; 760:375-7.
    View in: PubMed
    Score: 0.032
  5. Urinary calcium oxalate crystal growth inhibitors. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S46-53.
    View in: PubMed
    Score: 0.031
  6. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res. 1992 Sep; 7(9):1029-36.
    View in: PubMed
    Score: 0.027
  7. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11.
    View in: PubMed
    Score: 0.019
  8. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int. 1995 Jun; 47(6):1585-96.
    View in: PubMed
    Score: 0.008
  9. Upregulation of osteopontin expression by ischemia in rat kidney. Ann N Y Acad Sci. 1995 Apr 21; 760:321-3.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.